company? Let’s change
that.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
StimLabs was founded in 2015 with a desire to advance the state of regenerative medicine. In pursuit of this goal, StimLabs has gathered exceptional scientific and clinical minds to develop and commercialize new bioactive technologies. Within a year of its inception, StimLabs conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
Impiricus is the future of HCP-industry engagement. We build valuable tools, and curate trusted information for our network of providers. We partner with Pharma to identify the most impactful innovation to highlight. With the worlds first AI Concierge, we are supporting 1 mio patients get on therapy by 2025. Our physicians never have to fight an insurance company again. Want to learn more about why Impiricus is the fastest growing physician network today? or why engagement is over 90%? Find out more at: https://impiricus.com/partners/
RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service.
Omega Bio-tek provides nucleic acid purification solutions, offering products for clinical and basic research, biotech and agricultural applications.
360imaging is a 3D digital implantology provider offering a variety of products and services to implant professionals and their patients.
TAMM Net professionals provide biomedical companies with expertise in: •Obtaining reimbursement, •Researching government funding resources, •Providing solutions to regulatory issues and applications, and •Supplying distribution to closed systems. Everyone on the TAMM Net team has over 20 years of experience in their fields with documented success.
Clearwave is the healthcare industry’s most comprehensive patient engagement platform. Listed as one of Technology Association of Georgia's Top 40 Innovative Companies and a finalist for the 2020 TripleTree iAwards, Clearwave's technology has empowered specialty practices and health systems to improve profitability, productivity and patient access since 2004. Healthcare organizations choose Clearwave for its ability to simplify patient scheduling, expedite patient intake, automate insurance eligibility verification and create true financial transparency for both patient and practice. Clearwave helps practices accelerate cash flow and improve digital patient access. For more information, visit www.clearwaveinc.com. We aim to make the lives of specialty medical practices and health systems simpler, allowing them to focus on what truly matters – patient care.
Portal Innovations is a venture capital firm that helps exceptional life sciences innovators build their companies where they live. We surround these entrepreneurs with the resources and community they need: Seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.
NeuroLaunch is the world’s first accelerator program for neuroscience startups. We apply the methodology of lean early-stage company acceleration, which has risen to global prominence as a model for high-tech startups, to neuroscience.
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization.
Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.
Your partner in the diagnosis of inherited disease. MNG utilizes complex and innovative methods to deliver results that drive patient-centered decisions.
GEMÜ is a leading manufacturer of valves, measurement and control systems. Over the course of more than 50 years, this globally focused, independent family-owned enterprise has established itself in important industrial sectors thanks to its innovative products and customized solutions for process media control. GEMÜ is the world market leader for sterile valve applications in the pharmaceutical and biotechnology industries. Today, the GEMÜ Group employs about 100 people in the United States, 1000 employees in Germany and more than 1700 worldwide. Manufacturing is carried out at six manufacturing sites in Germany, Switzerland, China, Brazil, France and the USA.
Providing new objective data to help clinicians navigate infants to safer and faster independent oral feeding.
AlphaCord is a stem cell banking company.
Work Your Passion. Live Your Purpose.